Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by SSM0006on Dec 15, 2016 11:24am

20 Views

Post# 25604578

RE:RE:RE:Anyone know

Then let's hear your explanation?!?!? Or are you just bashing?

Eoj123 wrote:

SSM0006 wrote: My "gut" feeling yesterday was that Carmen was buying shares back. The buying spree may be over. If it is, I would think that we should start to rise again. Again, just my gut....

Your gut and your brain are not funtioning properly, that makes absolutly no sense.